These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 25483452)

  • 1. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
    Wefel JS; Kesler SR; Noll KR; Schagen SB
    CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
    Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
    Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-related cognitive impairment in older patients with cancer.
    Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
    J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Changes Related to Cancer Therapy.
    Vannorsdall TD
    Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
    Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, mechanisms, and management of cancer-related cognitive impairment.
    Janelsins MC; Kesler SR; Ahles TA; Morrow GR
    Int Rev Psychiatry; 2014 Feb; 26(1):102-13. PubMed ID: 24716504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-related cognitive impairment in children.
    Hutchinson AD; Pfeiffer SM; Wilson C
    Curr Opin Support Palliat Care; 2017 Mar; 11(1):70-75. PubMed ID: 28009650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
    Chung NC; Walker AK; Dhillon HM; Vardy JL
    Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
    Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
    Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
    Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
    Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer.
    Bolton G; Isaacs A
    Psychol Health Med; 2018 Dec; 23(10):1261-1274. PubMed ID: 30048158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients.
    Lycke M; Lefebvre T; Pottel L; Pottel H; Ketelaars L; Stellamans K; Eygen KV; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    J Psychosoc Oncol; 2017; 35(6):741-757. PubMed ID: 28816636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
    Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
    JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Drosophila model relevant to chemotherapy-related cognitive impairment.
    Torre M; Bukhari H; Nithianandam V; Zanella CA; Mata DA; Feany MB
    Sci Rep; 2023 Nov; 13(1):19290. PubMed ID: 37935827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review.
    Jia M; Zhang X; Wei L; Gao J
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):321-329. PubMed ID: 33079484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
    Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
    Front Neurol; 2022; 13():777808. PubMed ID: 35401389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-related cognitive impairment: the breast cancer experience.
    Myers JS
    Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.